Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-04-13 @ 7:45 AM
Study NCT ID:
NCT04270760
Status:
COMPLETED
Last Update Posted:
2025-05-09
First Post:
2020-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study
Sponsor:
Amgen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cardiovascular Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Olpasiran | View |
| None | AMG 890 | View |
| None | siRNA | View |
| None | lipoprotein (a) Lp(a) | View |
| None | Cardiovascular | View |
| None | Cardiovascular disease | View |
| None | Atherosclerotic cardiovascular disease | View |
| None | Cholesterol | View |
| None | Apolipoprotein (B) | View |
| None | Hyperlipidemia | View |
| None | Dyslipidemia | View |